Clinical trial
The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms
NCT04405193 is registered in ClinicalTrials.gov with Melva Louisa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms
- Lead sponsor
- Melva Louisa
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 1, 2019
- Completion date
- December 30, 2020
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
methamphetamine dependence in remission